In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.

Nicosia D., Federico A., Vigna I., Iozzo P., Misseri G., Cortegiani A. (2019). Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy. CLINICAL CASE REPORTS, 7(4), 665-667 [10.1002/ccr3.2061].

Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy

Nicosia D.;Iozzo P.;Misseri G.;Cortegiani A.
2019-01-01

Abstract

In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.
Nicosia D., Federico A., Vigna I., Iozzo P., Misseri G., Cortegiani A. (2019). Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy. CLINICAL CASE REPORTS, 7(4), 665-667 [10.1002/ccr3.2061].
File in questo prodotto:
File Dimensione Formato  
ccr3.2061.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 239.52 kB
Formato Adobe PDF
239.52 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/408940
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact